Optoacoustic tomography (OAT), also known as photoacoustic computed tomography (PACT), is an emerging imaging modality that shows promise in sensitivity for breast cancer detection, especially in dense breasts.1 – 4 OAT images exhibit greater detection sensitivity for highly vascularized, i.e., aggressive, breast tumors,5 and greater diagnostic specificity for all tumors over other modalities, such as x-ray mammography and ultrasound.1,5,6 Another advantage of OAT over x-ray mammography is that OAT does not involve ionizing radiation.1,2 Due to advances in OAT systems design and image reconstruction, a three-dimensional (3D) volumetric scan of the entire breast is now possible.3,5,7 At a single near-infrared illumination wavelength, natural chromophores in the breast tissue, such as hemoglobin, act as endogenous OAT contrast agents. From external ultrasound measurements of the pressure induced by the laser pulses, the spatial distribution of the chromophores can be estimated; this provides a qualitative, anatomical measure of the blood vasculature.3,5,7 – 10 Measurements from multiple illumination wavelengths matching the local maximum, minimum, and isosbestic point of deoxy- and oxyhemoglobin can be reconstructed into quantitative estimates of the blood oxygen saturation.5,11 – 16 This technology referred to as quantitative OAT (qOAT), also known as quantitative PACT, when combined with ultrasound, provides both anatomical and functional information of the breast that can facilitate detecting tumor angiogenesis and hypoxia.1